Vaccinex, Inc. ( VCNX) - Stock Earnings
VCNX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 16, 2026, midnight | — / — | — | — / — | — |
VCNX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | -5.7 million USD | 52000 USD |
| 2024Q4 | -3.4 million USD | 213000 USD |
| 2025Q1 | -3.4 million USD | 213000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VCNX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -19.7 million USD | 100000 USD |
| 2023 | -20.3 million USD | 570000 USD |
| 2024 | -18.6 million USD | 601000 USD |
| 2025 Est. | — | — |
VCNX
Price: $0.70
52 week price:
Earnings Per Share: -8.88 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 494085
Market Capitalization: 3.0 million